189 related articles for article (PubMed ID: 14499334)
1. Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.
Zheng QH; Fei X; DeGrado TR; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Mock BH; Glick-Wilson BE; Sullivan ML; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2003 Oct; 30(7):753-60. PubMed ID: 14499334
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.
Zheng QH; Fei X; Liu X; Wang JQ; Stone KL; Martinez TD; Gay DJ; Baity WL; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2004 Jan; 31(1):77-85. PubMed ID: 14741572
[TBL] [Abstract][Full Text] [Related]
3. [11C]Choline as a potential PET marker for imaging of breast cancer athymic mice.
Zheng QH; Stone KL; Mock BH; Miller KD; Fei X; Liu X; Wang JQ; Glick-Wilson BE; Sledge GW; Hutchins GD
Nucl Med Biol; 2002 Nov; 29(8):803-7. PubMed ID: 12453589
[TBL] [Abstract][Full Text] [Related]
4. Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor.
Furumoto S; Takashima K; Kubota K; Ido T; Iwata R; Fukuda H
Nucl Med Biol; 2003 Feb; 30(2):119-25. PubMed ID: 12623110
[TBL] [Abstract][Full Text] [Related]
5. [11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.
Zheng QH; Gardner TA; Raikwar S; Kao C; Stone KL; Martinez TD; Mock BH; Fei X; Wang JQ; Hutchins GD
Bioorg Med Chem; 2004 Jun; 12(11):2887-93. PubMed ID: 15142549
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues.
Fei X; Zheng QH; Wang JQ; Stone KL; Martinez TD; Miller KD; Sledge GW; Hutchins GD
Bioorg Med Chem Lett; 2004 Mar; 14(5):1247-51. PubMed ID: 14980675
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.
Zheng QH; Fei X; Liu X; Wang JQ; Bin Sun H; Mock BH; Lee Stone K; Martinez TD; Miller KD; Sledge GW; Hutchins GD
Nucl Med Biol; 2002 Oct; 29(7):761-70. PubMed ID: 12381456
[TBL] [Abstract][Full Text] [Related]
8.
Han N; Jiang Y; Gai Y; Liu Q; Yuan L; Wang Y; Li M; Zhang Y; Lan X
Contrast Media Mol Imaging; 2019; 2019():1760184. PubMed ID: 31787861
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.
Hofmann S; Maschauer S; Kuwert T; Beck-Sickinger AG; Prante O
Mol Pharm; 2015 Apr; 12(4):1121-30. PubMed ID: 25748228
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.
Fei X; Zheng QH; Liu X; Wang JQ; Sun HB; Mock BH; Stone KL; Miller KD; Sledge GW; Hutchins GD
Bioorg Med Chem Lett; 2003 Jul; 13(13):2217-22. PubMed ID: 12798337
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and initial PET imaging of new potential NK1 receptor radioligands 1-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-4-[11C]methyl-piperazine and {4-[2-(3,5-bis-trifluoromethyl-benzyloxy)-1-phenyl-ethyl]-piperazine-1-yl}-acetic acid [11C]methyl ester.
Gao M; Mock BH; Hutchins GD; Zheng QH
Nucl Med Biol; 2005 Jul; 32(5):543-52. PubMed ID: 15982585
[TBL] [Abstract][Full Text] [Related]
12. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
[TBL] [Abstract][Full Text] [Related]
13. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biodistribution of (11)C-GW7845, a positron-emitting agonist for peroxisome proliferator-activated receptor-{gamma}.
Mathews WB; Foss CA; Stoermer D; Ravert HT; Dannals RF; Henke BR; Pomper MG
J Nucl Med; 2005 Oct; 46(10):1719-26. PubMed ID: 16204723
[TBL] [Abstract][Full Text] [Related]
15. Antisense imaging of epidermal growth factor-induced p21(WAF-1/CIP-1) gene expression in MDA-MB-468 human breast cancer xenografts.
Wang J; Chen P; Mrkobrada M; Hu M; Vallis KA; Reilly RM
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1273-80. PubMed ID: 12640557
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vivo evaluation of novel PET radioligands for imaging the endothelin-A receptor.
Mathews WB; Murugesan N; Xia J; Scheffel U; Hilton J; Ravert HT; Dannals RF; Szabo Z
J Nucl Med; 2008 Sep; 49(9):1529-36. PubMed ID: 18703610
[TBL] [Abstract][Full Text] [Related]
17.
Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X
Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414
[TBL] [Abstract][Full Text] [Related]
18. 4-
Garg PK; Nazih R; Wu Y; Singh R; Garg S
J Nucl Med; 2017 May; 58(5):827-832. PubMed ID: 27980051
[TBL] [Abstract][Full Text] [Related]
19. S-11C-methyl-L-cysteine: a new amino acid PET tracer for cancer imaging.
Deng H; Tang X; Wang H; Tang G; Wen F; Shi X; Yi C; Wu K; Meng Q
J Nucl Med; 2011 Feb; 52(2):287-93. PubMed ID: 21233188
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evaluation of a Fluorine-18 (
Altine B; Gai Y; Han N; Jiang Y; Ji H; Fang H; Niyonkuru A; Bakari KH; Rajab Arnous MM; Liu Q; Zhang Y; Lan X
Mol Pharm; 2019 Nov; 16(11):4563-4571. PubMed ID: 31553879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
